Vitamin B3 (Niacin)

Vitamin B3 (Niacin) is an essential vitamin commonly considered for daily-wellness ranges. On DAT Supply briefs the positioning is set by the brand brief and reviewed against the target market’s claim rules — we do not pre-position an active for any single benefit. Editorial framing uses only applicable claims framework- or DSHEA-compatible wording — we never promote unauthorised claims, even when the active has consumer-side momentum. Format-wise we have considered Vitamin B3 (Niacin) for gummies, powder sachet, jelly and pet soft chew; the per-format formulation notes below describe the live constraints (taste, payload, stability, packaging) we tune in the formulation pass. Sourcing form (extract ratio for botanicals, salt or chelate form for minerals, free-form vs ester for amino acids) is reviewed against the brief, with documentation matched to the target market’s import rules. Inclusion rate and claim wording are reviewed per project — no two briefs land on the same combination, and we don’t publish off-the-shelf doses.

• Gummies
• Powder sachet
• Jelly

How we use Vitamin B3 (Niacin) in formulas

A public-safe formulation reference — how this active behaves in our formats, common pairings and handling notes. Final formulation, dose and on-pack copy are confirmed per project.

Heat stable

Limited — use coated forms

Soluble in matrix

Conditional

Vegan supply

Project-specific

US structure-function statements

Structure-function wording for this ingredient is reviewed per project against DSHEA (21 USC §343(r)(6)). No final on-pack copy is implied by this page.

Structure-function statements must appear with the FDA disclaimer in the same field of vision on the label. % Daily Value (DV) based on FDA 21 CFR 101.9.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Across the EU and UK markets Vitamin B3 (Niacin) is treated as a vitamin: any on-pack benefit wording must come from the applicable claims framework register (UK retains the same wording post-Brexit), and the inclusion rate has to meet the minimum thresholds tied to the chosen claim. For the US market, label benefit copy follows DSHEA structure-function rules with the standard "not intended to diagnose, treat, cure or prevent any disease" disclosure. We never reuse a market’s wording as if it carried over — claim copy is rewritten per market and reviewed per project. Country-level rules (e.g. France, Italy, Belgium for the EU; California Prop 65 for the US) layer on top, and the back-of-pack nutritional table is built against the market’s reference intake framework.

Vitamin B3 (Niacin) is measured by weight (mg) per serving on DAT Supply briefs. The working anchor — the inclusion rate against which target-market claim wording is reviewed — is set during the formulation pass for each project rather than published as a fixed number on the public page. Final per-serving load depends on the chosen format (gummy payload window, capsule fill weight, softgel oil load, sachet or powder scoop size, oral-liquid bottle geometry) and the claim wording the brand needs to support against the target market. Sourcing form (extract ratio, standardised marker, micronised vs granular, salt or chelate form) is reviewed in the same pass. Country-level upper limits (France, Italy, Belgium for the EU; California Prop 65 for the US) are checked before any inclusion rate is finalised. Dose is confirmed per project — we don’t publish off-the-shelf dose tables for any active in the catalogue.

The formulas above sit in these private-label ranges: